SCHEMBL2985619

SCHEMBL2985619

COC(=O)c1ccc(COc2ccccc2)cc1Cc1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
RAB9A P51151 1/20 0.46
ALOX5 P09917 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
TSHR P16473 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PTGER3 P43115 1/20 0.45
PTGDR Q13258 1/20 0.45
ADAMTS4 O75173 1/20 0.44
MMP13 P45452 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
PLA2G4B P0C869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908741 0.80 MAOB (0.56) MAOBRAB9AALOX5
SCHEMBL7908641 0.80 ALOX5 (0.55) MAOBALOX5
SCHEMBL7791330 0.78 RAB9A (0.62) MAOBRAB9AALOX5KDM4EMEN1
SCHEMBL14966933 0.78 KMT2A (0.55) MAOBRAB9ATSHRHSD17B10KDM4E
SCHEMBL12369490 0.77 HSD17B10 (0.51) RAB9ATSHRHSD17B10KDM4ELMNA
SCHEMBL2987086 0.77 ALOX5 (0.51) MAOBRAB9AALOX5PTGER3PTGDR
SCHEMBL2972861 0.77 HPGD (0.54) RAB9ATSHRHSD17B10KDM4ELMNA
SCHEMBL7787014 0.77 CAPN1 (0.57) RAB9AKDM4ELMNAHPGDNPSR1
SCHEMBL2979743 0.77 FFAR1 (0.57) MAOBPLA2G4B
Hydrochloric Acid SCHEMBL4221431 0.76 HSD17B10 (0.50) MAOBRAB9ATSHRHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786161-B2 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2010-08-31 US disclosed
US-20090318703-A1 CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD (JP) 2009-12-24 US disclosed
US-7491748-B2 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2009-02-17 US disclosed
US-20060258728-A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2006-11-16 US disclosed
EP-1431267-A1 CARBOXYLIC ACID DERIVATIVE COMPOUNDS AND DRUGS COMPRISING THESE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318703-A1 CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT PTGER2, PTGER4, PTGER1 MAOB 1424/4885RAB9A 3853/4885ALOX5 43/4885
US-20060258728-A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient PTGER2, PTGER4, PTGER1 MAOB 1078/4885RAB9A 3495/4885ALOX5 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.